EXACT Therapeutics AS: Minutes from the extraordinary general meeting

17 Dec 2024 12:00 CET

Oslo, 17 December 2024: Reference is made to the stock exchange announcements on
2 and 3 December 2024 regarding a private placement of new shares in EXACT
Therapeutics AS ("EXACT-Tx") raising gross proceeds of NOK 145 million (the
"Private Placement").

As part of the Private Placement, the board of directors of EXACT-Tx called for
an extraordinary general meeting to, inter alia, issue the tranche 2 shares (the
"EGM"). The EGM was held today, on 17 December 2024, and all proposals on the
agenda were adopted.

The minutes of the extraordinary general meeting are attached hereto and will be
available at www.exact-tx.com.

This information is subject to the disclosure requirements in section 5-12 of
the Norwegian Securities Trading Act.

For more information, please contact:

Per Walday, CEO
EXACT Therapeutics
Email per.walday@exact-tx.com

About EXACT Therapeutics:
EXACT Therapeutics is a clinical-stage precision medicine company utilizing the
power of ultrasound and microbubbles to enable targeted drug delivery in
oncology. Acoustic Cluster Therapy (ACT®) follows a unique approach and may be
applied to a wide range of therapeutic agents within oncology and across a
multitude of other indications including brain diseases. www.exact-tx.com

More information:
Access the news on Oslo Bors NewsWeb site

634940_EXACT Therapeutics AS - EGM minutes 17.12.2024 (signed).pdf